zeahealth/medstack-medimage-medtech-v1 huggingface dataset:
Brass sachet folder, 19th century. Graduated grey background. Wellcome Images
Attribution: "Brass sachet folder, 19th century. Graduated grey background Wellcome L0058549", wikimedia:Pharmaceutical industry via Wikimedia Commons, licensed cc-by-4.0. Source: https://upload.wikimedia.org/wikipedia/commons/7/77/Brass_sachet_folder%2C_19th_century._Graduated_grey_background_Wellcome_L0058549.jpg
"Heat map of individualized disclosure rates of 20 large pharmaceutical companies in Germany, Ireland, Italy, Spain, Sweden, Switzerland and the United Kingdom. Rates are presented as decimals (1.0 = 100%). Companies are listed based on average individualized disclosure rates. NA
Attribution: Authors of the study: Shai Mulinari, Luc Martinon, Pierre-Alain Jachiet, Piotr Ozieranski
"Non-R&D payments to healthcare professionals from 15 large pharmaceutical companies in Germany, Ireland, Italy, Spain, Sweden, Switzerland and the United Kingdom. (A) and (B) show payment totals, i.e. the sum of individualized and aggregate disclosures, and (C) show the individualized, monochrome black-and-white photograph
Attribution: Authors of the study: Shai Mulinari, Luc Martinon, Pierre-Alain Jachiet, Piotr Ozieranski
Посещение Зеленограда. С. Собянин // На фото пульт фармацевтического гранулятора (пеллетайзера) LGL200 производства Shandong SMA (Китай)
Attribution: Пресс-служба Мэра и Правительства Москвы
Timeline from 1975 showing the successful development of therapeutic antibodies and their applications. Many biotech companies that promised antibodies as anticancer “magic bullets” were launched from 1981 to 1986. The height of the line and numerical annotations represent the estimated
Finding: cancer
Diagnosis: cancer
Attribution: Ruei-Min Lu, Yu-Chyi Hwang, I-Ju Liu, Chi-Chiu Lee, Han-Zen Tsai, Hsin-Jung Li &amp; Han-Chung Wu